Abstract:Metastatic disease is the leading cause of cancer-related death, despite recent advances in therapeutic interventions. Prior modeling approaches have accounted for the adaptive immune system's role in combating tumors, which has led to the development of stochastic models that explain cancer immunoediting and tumor-immune co-evolution. However, cancer immune-mediated dormancy, wherein the adaptive immune system maintains a micrometastatic population by keeping its growth in check, remains poorly understood. Immune-mediated dormancy can significantly delay the emergence (and therefore detection) of metastasis. An improved quantitative understanding of this process will thereby improve our ability to identify and treat cancer during the micrometastatic period. Here, we introduce a generalized stochastic model that incorporates the dynamic effects of immunomodulation within the tumor microenvironment on T cell-mediated cancer killing. This broad class of nonlinear birth-death model can account for a variety of cytotoxic T cell immunosuppressive effects, including regulatory T cells, cancer-associated fibroblasts, and myeloid-derived suppressor cells. We develop analytic expressions for the likelihood and mean time of immune escape. We also develop a method for identifying a corresponding diffusion approximation applicable to estimating population dynamics across a wide range of nonlinear birth-death processes. Lastly, we apply our model to estimate the nature and extent of immunomodulation that best explains the timing of disease recurrence in bladder and breast cancer patients. Our findings quantify the effects that stochastic tumor-immune interaction dynamics can play in the timing and likelihood of disease progression. Our analytical approximations provide a method of studying population escape in other ecological contexts involving nonlinear transition rates.

Dynamic behavior of prostate cancer cells under antitumor immunity and pulse vaccination in a random environment

Simulating the Dynamic Intra-Tumor Heterogeneity and Therapeutic Responses

Evolutionary Dynamics Model of Prostate Cancer and Optimization of Treatment Strategies

Unlocking Immunity: Innovative prostate cancer vaccine strategies

Dynamical Behaviors of the Tumor-Immune System in a Stochastic Environment

Immunotherapy Vaccines for Prostate Cancer Treatment

Dynamics of a stochastic tumor–immune interaction system

Asymmetric non-Gaussian effects in a tumor growth model with immunization

Non-Gaussian dynamics of a tumor growth system with immunization

Mathematical Modeling Of Prostate Tumor Growth Under Intermittent Androgen Suppression With Partial Differential Equations

Agent-based modeling of the prostate tumor microenvironment uncovers spatial tumor growth constraints and immunomodulatory properties

A stochastic model for tumor growth with immunization

Mathematical modeling and dynamic analysis of anti-tumor immune response

A stochastic individual-based model for immunotherapy of cancer

An age-structured SIPC model of cervical cancer with immunotherapy

A MODEL AT THE MACROSCOPIC SCALE OF PROSTATE TUMOR GROWTH UNDER INTERMITTENT ANDROGEN SUPPRESSION

Moving on From Sipuleucel-T: New Dendritic Cell Vaccine Strategies for Prostate Cancer

Dynamic analysis of an antitumor model and investigation of the therapeutic effects for different treatment regimens

A partial differential equation model and its reduction to an ordinary differential equation model for prostate tumor growth under intermittent hormone therapy

How Modulation of the Tumor Microenvironment Drives Cancer Immune Escape Dynamics

Longtime evolution and stationary response of a stochastic tumor-immune system with resting T cells